Medications are still the most widespread first-line treatment option for glaucoma, but recent years have seen a growing trend toward a more proactive approach in which laser and surgery are considered earlier in the treatment algorithm.
Interventional glaucoma (IG) is gradually being embraced by an increasing number of surgeons who believe that a shift from the multiple medications treatment paradigm is possible, with clear and proven advantages in terms of effective glaucoma control, preservation of vision and patient quality of life.
In 2025, an Interventional Glaucoma Consensus Treatment